UNSPSC 51284131: Cefixime trihydrate

This classification denotes a cephalosporin antibiotic with the molecular formula C16H15N5O7S2.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 97I1C92E55, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-, trihydrate, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as cefixime trihydrate, which bears US NIH Compound Identifier 6321411.

European Medicines Agency schedules cefixime trihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07395MIG. Most nations, for tariff purposes, schedule cefixime trihydrate under HS 29419000. SMILES: C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3CSC(N3)N)SC1)C(=O)O.O.O.O.

UNSPSC 51284131 Cefixime trihydrate is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local opportunities tagged under it do not align with cefixime procurement. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—neither of which is cefixime trihydrate. Seminole County, Florida posted an IFB in June 2026 for Naloxone and Safe Drug Deactivation Systems, which falls outside pharmaceutical antibiotic scope entirely. The code appears to show minimal relevant recent activity; the two posted opportunities do not reflect procurement of cefixime or related third-generation cephalosporin formulations as the code name suggests.

The geographic spread evident in the opportunities—Illinois and Florida—does not indicate concentration of cefixime trihydrate procurement across state and local jurisdictions. Without additional opportunities demonstrating actual demand for cefixime trihydrate under this code, the mismatch between the code's nominal scope and what is actually being solicitated suggests limited current market activity for this specific commodity within the state and local procurement environment. Firms pursuing cefixime trihydrate contracts should verify coding and search broader pharmaceutical procurement channels or contact health departments directly rather than relying on this code as a reliable signal of active demand.